Overview

Treatment of Uterine Fibroids With Asoprisnil(J867)

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the safety and effectiveness of asoprisnil in symptomatic women with abnormal uterine bleeding associated with uterine fibroids.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott